Market revenue in 2023 | USD 186.5 million |
Market revenue in 2030 | USD 244.7 million |
Growth rate | 4% (CAGR from 2023 to 2030) |
Largest segment | Purity>98% |
Fastest growing segment | Purity>98% |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Purity>98%, Purity<98% |
Key market players worldwide | Merck KGaA, GSK PLC, Cipla Ltd DR, Novartis AG ADR, Sanofi SA, Aurobindo Pharma, Teva Pharmaceutical Industries Ltd, Mallinckrodt PLC Ordinary Shares - New, Cayman Chemical, Tokyo Chemical Industry, APExBIO Technology, Wilshire Technologies, Biosynth |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to crocin market will help companies and investors design strategic landscapes.
Purity>98% was the largest segment with a revenue share of 95.39% in 2023. Horizon Databook has segmented the Middle East & Africa crocin market based on purity>98%, purity<98% covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa, Saudi Arabia, Kuwait, and the UAE are some of the key prospering countries in the Middle East & Africa (MEA) region. The MEA crocin market is expected to be driven by the high prevalence of pain-causing disorders, headaches, & migraines; rise in consumer awareness; and improvements in healthcare infrastructure.
Economic development witnessed in emerging markets, such as South Africa, and high unmet healthcare needs are primary factors expected to drive this market. Moreover, the scope of this region as a major investment avenue has led to the market entry of major pharmaceutical manufacturers.
However, ethical complications, poor infrastructure, and affordability issues may hamper market growth over the forecast period. Moreover, the growing prevalence of various chronic conditions, which require paracetamol and combination drugs to manage pain, is expected to propel the market.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa crocin market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa crocin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account